BLACK WEEKSInjektiopullot −15 % · kitit −10 % · muut −5 %koodillaIlmainen toimitus Saksaan alk. €200

Tämä sivu on käännetty automaattisesti, ja siinä voi olla virheitä. Onko suomi äidinkielesi? Otamme mielellämme vastaan palautetta ja korjauksia.Lähetä palautetta

The Peptide Desk The Peptide Desk
Minoxidil, tuotekuva

Laboratorioraportti

PDF
Testattu
Testattu
Minoxidil 5mg × 100 Tabs
Laboratorio
Analiza Białek
Päivämäärä
October 2026
Tulos
5.33 mg per tablet (5 mg label)
Tilauksen nro
Salasana

Testattu riippumattomasti, tarkistettavissa salasanalla suoraan laboratoriossa.

Hair & Skin

Minoxidil

Hair & Skin

Tilaus

Kappalehinta - Ilmainen toimitus Saksaan yli 200 €:n tilauksille Black Weeksin aikana
  • DHL seurannalla
  • Huomaamaton pakkaus

4.6/5 Trustpilotissa73 arvostelua

Yhdellä silmäyksellä

Minoxidil lukuina

Tietopankkimme keskeiset luvut. Vedä pistettä käyrää pitkin nähdäksesi, paljonko yhden annoksen jälkeen on laskennallisesti jäljellä.

Koko tietopankkiartikkeli

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~4 hours

Half-life ~4 hours
After 8 hours: 25 %
Hour 450 %Hour 825 %Hour 1212.5 %Hour 203.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about4hours

Class
Vasodilatororal, low-dose
Use
Oral1x per day
Sizes
5 mg1 size in the shop

Tietoa

Kaikki aiheesta Minoxidil

Tarkemmat tiedot tulossa pian.

Annostelu

Ladataan annostelutietoja …

Lisää tietopankissa

FAQ

Usein kysyttyä

Lähteet jokaiseen vastaukseen: tietopankkiartikkeli

Onko sinulla vielä kysyttävää?

Kirjoita meille, tiimimme auttaa sinua.

How does minoxidil act on hair?

It is not fully understood. In animal models minoxidil shortens the resting phase, resting follicles switch to growth earlier, the growth phase gets longer and the follicle larger. The active form is the sulfate, which opens potassium channels. Such channels were found in the dermal papilla of human hair follicles. In culture minoxidil and a channel blocker cancelled each other out.

Is minoxidil approved as a tablet?

The compound is: ChEMBL lists minoxidil with phase 4 as the highest phase and first approval in 1979. As a tablet it lowers blood pressure via the vessels. For hair loss the low-dose tablet is used off-label. A phase 3 trial in women is running on the registry, one with tablets under the tongue in men has been completed.

Is the tablet better than the solution applied to the scalp?

In a double-blind trial with 90 men (68 analysed) the tablet was not superior after 24 weeks. The gain in hair density was somewhat higher at the vertex, but not statistically significant. Only the photo assessment put the tablet ahead at the vertex. Its advantage is more about daily life: no daily application. The solution itself is well studied: in a trial with 393 men the higher-concentration solution grew clearly more hair over 48 weeks than the lower-concentration one or placebo.

Why does it not work equally for everyone?

Minoxidil is activated in the hair follicle by the enzyme sulfotransferase. In a study with 41 patients hair loss improved in 63.4 percent after 6 months, more often in men than in women. Surprisingly, patients with low enzyme activity responded better (85 against 43 percent). The authors see this as a way to estimate beforehand who benefits.

Which side effects were seen?

In the largest analysis with 1,404 patients increased body hair was most common (15.1 percent). Lightheadedness (1.7), fluid retention (1.3), racing heart (0.9), headache (0.4), swelling around the eyes (0.3) and sleep problems (0.2 percent) were rare, 1.7 percent stopped. In a small trial in men almost half had more body hair.

Does it also help with diffuse shedding?

In chronic telogen effluvium, long-lasting diffuse shedding without bald patches, it was studied in 36 women. The shedding score fell from 5.64 by 1.7 points after 6 months and by 2.58 points after 12 months. Blood pressure barely changed, 13 women developed more facial hair. It was a retrospective analysis without placebo.

How good is the overall evidence?

A review found 17 studies with 634 patients in total up to April 2020, mostly on pattern hair loss, plus other forms. It rates the tablet as effective and well tolerated for healthy people who struggle with the solution. According to the authors larger randomised trials comparing doses are still missing.

Liittyvät

Samankaltaiset tuotteet